Christopher Heery - May 9, 2023 Form 4 Insider Report for Arcellx, Inc. (ACLX)

Role
Chief Medical Officer
Signature
/s/ Rami Elghandour, as Attorney-in-Fact
Stock symbol
ACLX
Transactions as of
May 9, 2023
Transactions value $
-$121,766
Form type
4
Date filed
5/11/2023, 04:10 PM
Previous filing
May 8, 2023
Next filing
Jul 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACLX Common Stock Sale -$22.5K -500 -4.77% $45.00 9.99K May 9, 2023 Direct F1
transaction ACLX Common Stock Sale -$99.3K -2.2K -21.99% $45.18 7.8K May 10, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 30, 2022.
F2 Represents the weighted average share price of an aggregate total of 2,197 shares sold in the price range of $45.00 to $45.72 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.